Pamezol (Esomeprazole)

Esomeprazole, the active ingredient in Pamezol, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid and is used to treat gastro‑intestinal ulcer conditions and related acid‑related disorders in adults.

GNH USA supplies Pamezol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole is a proton pump inhibitor that acts on acid‑related gastrointestinal conditions. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to esomeprazole are generally mild to moderate and vary with individual sensitivity.

Common Side Effects: - Headache: mild and transient. - Diarrhea: usually self‑limiting. - Nausea: occasional and mild. - Abdominal pain: intermittent discomfort. - Flatulence: excess gas. - Constipation: occasional bowel change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Low magnesium levels (hypomagnesemia): can lead to muscle cramps or arrhythmias. - Fracture risk: long‑term use may be associated with increased bone fracture risk. - Liver enzyme elevation: may indicate hepatic stress. - Stevens‑Stevens Johnson syndrome: rare but serious skin reaction.

When prescribing esomeprazole, clinicians should consider several safety aspects. - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for magnesium levels: especially during prolonged therapy. - Evaluate bone health: consider calcium/vitamin D supplementation for long‑term users. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Esomeprazole can affect the absorption and metabolism of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect may increase cardiovascular risk. - Atazanavir: decreased antiviral efficacy due to reduced gastric acidity. - Methotrexate (high dose): increased systemic exposure and toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Digoxin: may increase serum concentrations. - Phenytoin: possible reduction in serum levels. - Ketoconazole: reduced absorption requiring dosage adjustment.